| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 179899-07-1 | 4-Fluoro-2-methoxyphenylboronic acid | C7H8BFO3 |
| 179923-32-1 | 2,3,4,5-Tetrafluorophenylboronic acid | C6H3BF4O2 |
| 179932-05-9 | 3-Thiophenepropanoic acid methyl ester | C8H10O2S |
| 179943-57-8 | Ethyl 7-bromo-4-hydroxyquinoline-3-carboxylate | C12H10BrNO3 |
| 179946-34-0 | 2-Fluoro-6-(trifluoromethyl)phenylacetonitrile | C9H5F4N |
| 179993-02-3 | (R)-((2-(Bromomethyl)-3-methylbutoxy)methyl)benzene | C13H19BrO |
| 180003-17-2 | Estrone 3-oleate | C36H54O3 |
| 180031-78-1 | 4-[(2-Furanylmethyl)thio]-2-pentanone | C10H14O2S |
| 180045-74-3 | N-[[(3,5-Dichlorophenyl)amino][(diphenylmethyl)amino]methylene]-glycine | C22H19Cl2N3O2 |
| 180048-73-1 | 2-Hydroxy-2-methyl-1-(4-(methylsulfonyl)phenyl)propan-1-one | C11H14O4S |
| 180064-38-4 / 127657-42-5 | Minodronic acid | C9H12N2O7P2 |
| 180083-23-2 | SB 224289 | C32H32N4O3 |
| 180088-52-2 | 7-[[2-Deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl]oxy]-4-methyl-2H-1-benzopyran-2-one | C16H19NO10S |
| 180134-15-0 | 2-Methoxy-4,6-bis(trifluoromethyl)benzoic acid | C10H6F6O3 |
| 180134-21-8 | 4-Fluoro-2,6-dichloronitrobenzene | C6H2Cl2FNO2 |
| 180160-40-1 | 6-Chlorospiro[isobenzofuran-1(3H),4'-piperidin]-3-one | C12H12ClNO2 |
| 180160-47-8 | 5-Chlorospiro[isobenzofuran-1(3H),4'-piperidin]-3-one | C12H12ClNO2 |
| 180160-48-9 | 5-Chlorospiro[isobenzofuran-1(3H),4'-piperidine] | C12H14ClNO |
| 180160-93-4 | 5-Chloro-1,3-dihydrospiro[isobenzofuran-3,4'-piperidine] | C12H14ClNO |
| 180160-97-8 | 3,4-Dihydrospiro[isochromene-1,4'-piperidine] | C13H17NO |
| 180164-14-1 | 4-(3-Hydroxy-1-butenyl)-3,5,5-trimethyl-1,2,4-cyclohexanetriol | C13H24O4 |
| 180181-93-5 | beta-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]benzenepropanoic acid | C24H21NO4 |
| 180186-94-1 | (3aR,3'aR,8aS,8'aS)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] | C21H18N2O2 |
| 180196-56-9 | (1R,3S)-3-Aminocyclopentanecarboxylic acid methyl ester hydrochloride | C7H13NO2.HCl |
| 180200-66-2 | Gatifloxacin sesquihydrate | C19H22FN3O4.1,5(H2O) |
| 180205-28-1 | 1-(Aminomethyl)cyclobutanol1-(Aminomethyl)cyclobutanol | C5H11NO |
| 180205-34-9 | (1-Aminocyclobutyl)methanol | C5H11NO |
| 180207-57-2 | 2-(1H-Pyrazol-4-yl)ethanol | C5H8N2O |
| 180253-66-1 | (4-Methylpyridin-3-yl)carbamic acid tert-butyl ester | C11H16N2O2 |
| 180258-46-2 | 4-Amino-N-methylimidazole-2-carboxylic acid ethyl ester hydrochloride | C7H11N3O2.HCl |
| 180263-44-9 | 3-Amino-3-[4-(trifluoromethyl)phenyl]propanoic acid | C10H10F3NO2 |
| 180272-14-4 | Solifenacin | C23H26N2O2 |
| 180272-28-0 | Solifenacin N1-oxide | C23H26N2O3 |
| 180272-43-9 | 1,2,3,4-Tetrahydro-1-(4-pyridinyl)isoquinoline | C14H14N2 |
| 180272-45-1 | (R)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline | C15H15N |
| 180287-02-9 | Methyl 2-fluoro-3-oxovalerate | C6H9FO3 |
| 180288-69-1 | Trastuzumab | C6470H10012N1726O2013S42 |
| 180307-56-6 | tert-Butyl 4-vinylpiperidine-1-carboxylate | C12H21NO2 |
| 180316-10-3 | 3-(2-Propenylseleno)-L-alanine | C6H11NO2Se |
| 180323-49-3 | (1S,3R)-3-Aminocyclopentanecarboxylic acid methyl ester hydrochloride | C7H13NO2.HCl |
| 180336-27-0 | 2,6-Anhydro-3-deoxy-D-lyxo-hept-2-enononitrile | C7H9NO4 |
| 180336-29-2 | 2,6-Anhydro-3-deoxy-D-lyxo-hept-2-enonimidamide monohydrochloride | C7H12N2O4.HCl |
| 180340-69-6 | 6-Amino-5-bromonicotinic acid | C6H5BrN2O2 |
| 180340-70-9 | Methyl 6-amino-5-bromonicotinate | C7H7BrN2O2 |
| 180387-75-1 | L-alpha-Glutamyl-L-lysyl-L-prolyl-L-leucyl-L-glutaminyl-L-asparaginyl-L-phenylalanyl-L-threonyl-L-leucyl-L-cysteinyl-L-phenylalanyl-L-argininamide | C68H107N19O17S |
| 180387-76-2 | L-Phenylalanyl-L-threonyl-L-leucyl-L-cysteinyl-L-phenylalanyl-L-argininamide | C37H56N10O7S |
| 180414-94-2 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-5-methyl-L-norleucine | C22H25NO4 |
| 180420-84-2 | 1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-4-methyl-1H-indole | C14H17NO3 |
| 180465-84-3 | Spiro[indoline-3,4'-piperidine]-1'-carboxylic acid tert-butyl ester | C17H24N2O2 |
| 180468-39-7 | Solifenacin hydrochloride | C23H26N2O2.HCl |